Ilsung Pharm (003120) — Net Asset Quality Index
Ilsung Pharm (003120) has a Net Asset Quality Index of 95.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩403.01 Billion minus total liabilities of ₩16.67 Billion yields net assets of ₩386.34 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Ilsung Pharm defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ilsung Pharm Net Asset Quality Index Over Time (2013–2025)
This chart shows how Ilsung Pharm's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 95.9%, representing net assets of ₩386.34 Billion against total assets of ₩403.01 Billion KRW. Explore Ilsung Pharm cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Ilsung Pharm (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Ilsung Pharm from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Ilsung Pharm market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.9% | ₩386.34 Billion | ₩403.01 Billion | ₩16.67 Billion | ▼ -1.2 pp |
| 2024 | 97.0% | ₩385.13 Billion | ₩396.88 Billion | ₩11.75 Billion | ▲ +5.7 pp |
| 2023 | 91.3% | ₩382.75 Billion | ₩419.19 Billion | ₩36.44 Billion | ▲ +1.2 pp |
| 2022 | 90.1% | ₩445.57 Billion | ₩494.42 Billion | ₩48.85 Billion | ▼ -3.0 pp |
| 2021 | 93.1% | ₩345.91 Billion | ₩371.38 Billion | ₩25.47 Billion | ▼ -0.5 pp |
| 2020 | 93.6% | ₩347.48 Billion | ₩371.22 Billion | ₩23.75 Billion | ▲ +0.1 pp |
| 2019 | 93.5% | ₩345.49 Billion | ₩369.52 Billion | ₩24.03 Billion | ▲ +0.1 pp |
| 2018 | 93.4% | ₩324.34 Billion | ₩347.26 Billion | ₩22.93 Billion | ▲ +0.5 pp |
| 2017 | 92.9% | ₩322.83 Billion | ₩347.46 Billion | ₩24.64 Billion | ▼ -1.7 pp |
| 2016 | 94.6% | ₩320.10 Billion | ₩338.50 Billion | ₩18.40 Billion | ▲ +7.8 pp |
| 2015 | 86.7% | ₩318.34 Billion | ₩367.03 Billion | ₩48.69 Billion | ▼ -0.1 pp |
| 2014 | 86.9% | ₩328.68 Billion | ₩378.37 Billion | ₩49.69 Billion | ▲ +0.3 pp |
| 2013 | 86.6% | ₩322.74 Billion | ₩372.66 Billion | ₩49.92 Billion | — |